Science and Health News

Popular Tags

research medical and health science cancer health Hi-Tech DNA medicine aging Industry stem cells brain genomics COVID-19 Alzheimer's disease diabetes heart Illness Parkinson’s disease dementia study HIV vaccine longevity hiv blood RNA Immunology medical technology CRISPR infection cells Alzheimer 3D printing parkinson obesity genome FDA biology genetics artificial intelligence transplant biotechnology bioprinting coronavirus transplantation Alzheimer’s disease Zika virus bioengineering cancer cells

November 29, 2022, 15:13

FDA Approves First Gene Therapy to Treat Adults with Hemophilia B

The U.S. Food and Drug Administration approved Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.

hemophilia

Site Map